Achieve life sciences to announce first quarter financial results and host conference call and webcast on may 9, 2024

Seattle and vancouver, british columbia, april 25, 2024 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced it will report its first quarter 2024 financial results and provide an update on the cytisinicline development program on thursday, may 9, 2024, at 4:30 pm edt.
ACHV Ratings Summary
ACHV Quant Ranking